| scholarly article | Q13442814 |
| P50 | author | Jan J. Enghild | Q38523587 |
| Carsten Scavenius | Q40051555 | ||
| P2093 | author name string | Camilla Lund Nikolajsen | |
| Ebbe Toftgaard Poulsen | |||
| Thomas F Dyrlund | |||
| P2860 | cites work | Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells | Q24291100 |
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| Plasma fibronectin promotes thrombus growth and stability in injured arterioles | Q30477630 | ||
| Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database | Q33221802 | ||
| Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. | Q33240965 | ||
| The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes | Q33761129 | ||
| In vivo near-infrared imaging of fibrin deposition in thromboembolic stroke in mice | Q34137616 | ||
| Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase | Q34218459 | ||
| Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. | Q34311804 | ||
| MS Data Miner: a web-based software tool to analyze, compare, and share mass spectrometry protein identifications | Q34352042 | ||
| Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi | Q34591264 | ||
| Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 | ||
| Factor XIII and the clotting of fibrinogen: from basic research to medicine | Q36174621 | ||
| Complement and coagulation: strangers or partners in crime? | Q36750470 | ||
| Transdab wiki: the interactive transglutaminase substrate database on web 2.0 surface | Q37205084 | ||
| Harmful molecular mechanisms in sepsis | Q37273299 | ||
| Arterial thrombus formation in cardiovascular disease | Q37897474 | ||
| Factor XIII: a coagulation factor with multiple plasmatic and cellular functions | Q37899674 | ||
| Substrates of Factor XIII-A: roles in thrombosis and wound healing | Q38052936 | ||
| New developments in the area of factor XIII. | Q38070913 | ||
| Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix | Q38342850 | ||
| Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis | Q40684825 | ||
| Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci | Q40877431 | ||
| Analysis of transglutaminase protein substrates by functional proteomics. | Q42141647 | ||
| Covalent crosslinking of von Willebrand factor to fibrin | Q42201647 | ||
| The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking. | Q42326716 | ||
| Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides | Q42793174 | ||
| Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination | Q46399177 | ||
| Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction. | Q46752654 | ||
| Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. | Q46804676 | ||
| Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme | Q46964224 | ||
| Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. | Q52721248 | ||
| Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting | Q53849449 | ||
| Catalytic life of activated factor XIII in thrombi. Implications for fibrinolytic resistance and thrombus aging. | Q54038073 | ||
| Factor V is a substrate for the transamidase factor XIIIa | Q69884610 | ||
| Bovine histidine-rich glycoprotein is a substrate for bovine plasma factor XIIIa | Q72675729 | ||
| Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin | Q77387645 | ||
| Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin | Q77812986 | ||
| Factor XIII deficiency | Q83181285 | ||
| Human complement C3 is a substrate for transglutaminases. A functional link between non-protease-based members of the coagulation and complement cascades | Q84219036 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6526-6534 | |
| P577 | publication date | 2014-01-17 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot | |
| P478 | volume | 289 |
| Q60184480 | Achieving Controlled Biomolecule-Biomaterial Conjugation |
| Q37615581 | Advances of Coagulation Factor XIII |
| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q37216285 | Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII. |
| Q59333071 | Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism |
| Q35153828 | Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay. |
| Q102320366 | F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes |
| Q33944224 | Factor XIII activity mediates red blood cell retention in venous thrombi |
| Q36169271 | Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking |
| Q90051307 | Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function |
| Q92493108 | Identification of Potential Novel Interacting Partners for Coagulation Factor XIII B (FXIII-B) Subunit, a Protein Associated with a Rare Bleeding Disorder |
| Q53730774 | Inhibition of Fibrinolysis by Coagulation Factor XIII. |
| Q55356191 | Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis. |
| Q38801273 | Newly-Recognized Roles of Factor XIII in Thrombosis |
| Q38840345 | Novel aspects of platelet factor XIII function |
| Q51092901 | Novel hemostatic agents based on gelatin-microbial transglutaminase mix. |
| Q35948493 | Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII. |
| Q90388919 | Structure-Based Design of FXIIIa-Blockers: Addressing a Transient Hydrophobic Pocket in the Active Site of FXIIIa |
| Q93051715 | Transglutaminase inhibition stimulates hematopoiesis and reduces aggressive behavior of crayfish, Pacifastacus leniusculus |
| Q58122380 | [Variation of expression level and activity of coagulation factor ⅩⅢ in acute myeloid leukemia patients] |
Search more.